Title: Sharon Rosenzweig-Lipson: Innovator in Cognitive Impairment Treatments
Introduction
Sharon Rosenzweig-Lipson is a notable inventor based in East Brunswick, NJ (US). She is currently associated with Agenebio, Inc., where she focuses on developing innovative treatments for cognitive impairment. Despite having no granted patents, her contributions to the field are significant.
Latest Patent Applications
Sharon's latest patent applications include:
1. **Combinations of GABAA Alpha 5 Agonists and SV2A Inhibitors and Methods of Using in the Treatment of Cognitive Impairment** - This application discusses methods and pharmaceutical compositions for treating cognitive impairment associated with central nervous system (CNS) disorders. It emphasizes the use of SV2A inhibitors in combination with GABAα5 receptor agonists for various cognitive impairments, including Alzheimer's disease and Parkinson's disease.
2. **Extended Release Pharmaceutical Compositions of Levetiracetam** - This invention relates to novel extended release formulations of levetiracetam, aimed at treating cognitive impairment associated with CNS disorders.
Conclusion
Sharon Rosenzweig-Lipson is making strides in the field of cognitive impairment treatments through her innovative research and patent applications. Her work holds promise for improving the lives of individuals affected by various CNS disorders.